Zevra Therapeutics, Inc.

États‑Unis d’Amérique


Commandez votre montre hebdomadaire Zevra Therapeutics, Inc.
Quantité totale PI 99
Rang # Quantité totale PI 13 519
Note d'activité PI 2,5/5.0    38
Rang # Activité PI 19 625
Symbole boursier ZVRA (nasdaq)
ISIN US4884452065
Capitalisation 488M  (USD)
Classe Nice dominante Services scientifiques, technolo...

Brevets

Marques

71 13
11 0
4 0
0
 
Dernier brevet 2025 - Gamma-hydroxybutyrate delivering...
Premier brevet 2010 - Benzoic acid, benzoic acid deriv...
Dernière marque 2025 - APADAZ
Première marque 2006 - KEMPHARM

Industrie (Classification de Nice)

Derniers inventions, produits et services

2025 Invention Gamma-hydroxybutyrate delivering compounds and processes for making and using them. Disclosed ar...
P/S Pharmaceutical preparations for the treatment of pain
2024 Invention Levorphanol prodrugs and processes for making and using them. The presently described technology...
Invention Dextrorphan prodrugs and processes for making and using them. The presently described technology...
Invention D-amphetamine compounds, compositions, and processes for making and using the same. Discloses ar...
2023 Invention Ketamine compounds and processes for making and using them. Disclosed are compounds comprising k...
Invention Gamma-hydroxybutyrate delivering compounds and processes for making and using them. Disclosed are...
P/S Drug discovery services; Medical research; Research and development in the field of drug discovery
2022 Invention Ketamine compounds and processes for making and using them. Disclosed are compounds comprising ke...
2021 Invention Levorphanol prodrugs and processes for making and using them. The presently described technology ...
Invention Dextrorphan prodrugs and processes for making and using them. The presently described technology ...
Invention D-amphetamine compounds, compositions, and processes for making and using the same. Disclosed are...
Invention Compositions comprising methylphenidate-prodrugs, processes of making and using the same. The pr...
2020 Invention Compositions comprising methylphenidate-prodrugs, processes of making and using the same. The pre...
2019 Invention Therapeutic formulation for reduced drug side effects. The present invention provides drug therap...
Invention Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of oxymorphone, ...
Invention Methylphenidate-prodrugs, processes of making and using the same. The present technology is direc...
Invention Pharmaceutically acceptable salts and polymorphic forms of hydrocodone benzoic acid enol ester an...
Invention Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydromorphone...
2018 Invention Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, ...
Invention Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of oxycodone, pr...
P/S Pharmaceutical preparations for the treatment of pain Drug discovery services; Medical research; ...
2017 P/S Providing educational information in the field of new product research and development, medical c...
P/S Drug discovery services; Drug discovery services conducted by means of a scientific laboratory co...
Invention Fatty acid conjugates of quetiapine, process for making and using the same. The presently describ...
Invention Amino acid conjugates of quetiapine, process for making and using the same. The presently describ...
2006 P/S MEDICAL RESEARCH